Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Short Interest Up 91.7% in January

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY - Get Free Report) saw a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 65,000 shares, a growth of 91.7% from the January 15th total of 33,900 shares. Based on an average daily trading volume, of 471,700 shares, the days-to-cover ratio is presently 0.1 days.

Daiichi Sankyo Trading Down 2.3 %

OTCMKTS:DSNKY traded down $0.56 during midday trading on Monday, reaching $23.89. 199,873 shares of the stock traded hands, compared to its average volume of 213,522. The company has a fifty day moving average of $27.21 and a 200 day moving average of $32.07. Daiichi Sankyo has a 12 month low of $22.80 and a 12 month high of $42.48.

Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.22 EPS for the quarter. On average, research analysts predict that Daiichi Sankyo will post 0.82 earnings per share for the current year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.